Featured series 
Tag: National Institute of Neurological Disorders and Stroke.
-
Nation & World
‘Sunshine vitamin’ looks a little brighter
Adequate levels of vitamin D during young adulthood could cut the risk of adult-onset type 1 diabetes by as much as 50 percent, according to new findings by researchers at the Harvard School of Public Health.
-
Nation & World
Personalized medicine closer to reality
A consortium of scientists at 20 institutions, led by a principal faculty member at the Harvard Stem Cell Institute, has used stem cells to take a major step toward developing personalized medicine to treat Parkinson’s disease.
-
Nation & World
Biomarker for Huntington’s identified
In a new research paper published in the Proceedings of the National Academy of Sciences Early Edition online, Harvard-affiliated researchers identify a transcriptional biomarker that may assist in the monitoring of Huntington’s disease activity and in the evaluation of new medications.
-
Nation & World
Clearer view of Parkinson’s
A new study finds that a protein key to Parkinson’s disease has likely been mischaracterized. The protein, alpha-synuclein, appears to have a radically different structure in healthy cells than previously thought, challenging existing disease paradigms and suggesting a new therapeutic approach.
-
Nation & World
Study: Ibuprofen cuts Parkinson’s risk
A new study by Harvard School of Public Health researchers shows that adults who regularly take ibuprofen, a nonsteroidal anti-inflammatory drug, have about one-third less risk of developing Parkinson’s disease than nonusers.
-
Nation & World
Dairy fat may help not harm
Scientists at the Harvard School of Public Health and collaborators from other institutions have identified a natural substance in dairy fat that may substantially reduce the risk of type 2 diabetes.
